Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease
- 15 June 2010
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 48 (12), 1570-1576
- https://doi.org/10.1016/j.freeradbiomed.2010.02.016
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brainFree Radical Biology & Medicine, 2008
- The Academic Alliance for AIDS Care and Prevention in AfricaAcademic Medicine, 2008
- Clinical Trials and Medical Care: Defining the Therapeutic MisconceptionPLoS Medicine, 2007
- Formation of Nɛ-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modificationJournal of Lipid Research, 2006
- The New Medical “Missionaries” — Grooming the Next Generation of Global Health WorkersNew England Journal of Medicine, 2006
- Packing and Viscoelasticity of Polyunsaturated ω-3 and ω-6 Lipid Bilayers as Seen by 2H NMR and X-ray DiffractionJournal of the American Chemical Society, 2005
- Protein‐Bound AcroleinJournal of Neurochemistry, 1999
- Oxidative damage to mitochondrial DNA is increased in Alzheimer's diseaseAnnals of Neurology, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology & Medicine, 1991